References
- Brosnan, J. T., Jacobs, R. L., Stead, L. M., & Brosnan, M. E. (2004). Methylation demand: A key determinant of homocysteine metabolism. Acta Biochemica Polonica, 51, 405–413.
- Doets, E. L., van Wijngaarden, J. P., & Szczecinska, A. (2012). Vitamin B12 intake and status and cognitive function in elderly people. Epidemiologic Reviews, 10, 1093. doi:10.1093/epirev/mxs003
- Ellinson, M., Thomas, J., & Patterson, A. (2004). A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. Journal of Human Nutrition and Dietetics: The Official Journal of the British Dietetic Association, 17, 371–383. doi:10.1111/j.1365-277X.2004.00532.x
- Flatley, J. E., Garner, C. M., Al-Turki, M., Manning, N. J., Olpin, S. E., Barker, M. E., & Powers, H. J. (2012). Determinants of urinary methylmalonic acid concentration in an elderly population in the United Kingdom. The American Journal of Clinical Nutrition, 95, 686–693. doi:10.3945/ajcn.111.024133
- Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198. doi:10.1016/0022-3956(75)90026-6
- Lildballe, D. L., Fedosov, S., Sherliker, P., Hin, H., Clarke, R., & Nexo, E. (2011). Association of cognitive impairment with combinations of vitamin B12-related parameters. Clinical Chemistry, 57, 1436–1443. doi:10.1373/clinchem.2011.165944
- Morris, M. (2012). The role of B vitamins in preventing and treating cognitive impairment and decline. Advances in Nutrition, 3, 801–812. doi:10.3945/an.112.002535
- Sechi, G. P., Sechi, E., Fois, C., & Kumar, N. (2016). Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults. Nutrition Reviews, 74, 281–300. doi:10.1093/nutrit/nuv107
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., … Wolf, P. A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. New England Journal of Medicine, 346, 476–483. doi:10.1056/NEJMoa011613